These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38739231)

  • 41. Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood.
    Aalbers AM; van den Heuvel-Eibrink MM; Baumann I; Dworzak M; Hasle H; Locatelli F; De Moerloose B; Schmugge M; Mejstrikova E; Nováková M; Zecca M; Zwaan CM; Te Marvelde JG; Langerak AW; van Dongen JJ; Pieters R; Niemeyer CM; van der Velden VH
    Haematologica; 2015 Mar; 100(3):315-23. PubMed ID: 25425683
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A new disease categorization of low-grade myelodysplastic syndromes based on the expression of cytopenia and dysplasia in one versus more than one lineage improves on the WHO classification.
    Verburgh E; Achten R; Louw VJ; Brusselmans C; Delforge M; Boogaerts M; Hagemeijer A; Vandenberghe P; Verhoef G
    Leukemia; 2007 Apr; 21(4):668-77. PubMed ID: 17301818
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chimeric antigen receptor T-cell immunotherapies adverse events reported to FAERS database: focus on cytopenias.
    Gomez-Lumbreras A; Mercadal Vilchez S; Villa-Zapata L; Malone DC; Couriel DR
    Leuk Lymphoma; 2023 Dec; 64(13):2071-2080. PubMed ID: 37708442
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Myelodysplastic syndrome with early presentation of refractory monolineage cytopenia-with report of 13 cases].
    Cheng SC; Yu YF; Li SL; Wang YZ; Ge CW; Feng SF; Liu HL; Liang WT
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Aug; 10(4):303-6. PubMed ID: 12513762
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Linezolid Exposure Is Associated with Cytopenias in Patients Treated for Multidrug-Resistant Tuberculosis.
    Graciaa DS; Kipiani M; Magee MJ; Mikiashvili L; Barbakadze K; Bablishvili N; Auld SC; Alghamdi WA; Alshaer MH; Peloquin CA; Avaliani Z; Blumberg HM; Kempker RR
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0040822. PubMed ID: 35916515
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prior cytopenia predicts worse clinical outcome in acute myeloid leukemia.
    Huck A; Pozdnyakova O; Brunner A; Higgins JM; Fathi AT; Hasserjian RP
    Leuk Res; 2015 Oct; 39(10):1034-40. PubMed ID: 26220865
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of latent feline leukemia virus infection in nonregenerative cytopenias of cats.
    Stützer B; Müller F; Majzoub M; Lutz H; Greene CE; Hermanns W; Hartmann K
    J Vet Intern Med; 2010; 24(1):192-7. PubMed ID: 19925574
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution Experience.
    Schaefer A; Huang Y; Kittai A; Maakaron JE; Saygin C; Brammer J; Penza S; Saad A; Jaglowski SM; William BM
    Cancer Manag Res; 2021; 13():8901-8906. PubMed ID: 34876852
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prolonged cytopenias after immune effector cell therapy and lymphodepletion in patients with leukemia, lymphoma and solid tumors.
    Miller A; Daum R; Wang T; Wu M; Tat C; Pfeiffer T; Navai S; Heczey A; Hegde M; Ahmed N; Whittle SB; Hill L; Martinez C; Krance R; Ramos CA; Rouce RH; Lulla P; Heslop HE; Omer B; Shekar M
    Cytotherapy; 2024 May; ():. PubMed ID: 38819365
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Letermovir for pre-emptive cytomegalovirus therapy after allogeneic hematopoietic cell transplantation.
    Kaur R; Purtill D; Cooney J; Cannell P; Wright M; Copeland TS; McGuire M; Boan P
    Transpl Infect Dis; 2023 Nov; 25 Suppl 1():e14147. PubMed ID: 37676725
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Late-Onset Hematological Toxicity (LOHT) in Patients with B-Cell Lymphomas: A Survey in 758 Cases.
    Palacios-Campos A; Dueñas-González A; Gutiérrez-Hernández O; Candelaria-Hernández M
    Rev Invest Clin; 2020 May; 73(5):. PubMed ID: 33057325
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical and pathological features of clonal cytopenia of undetermined significance presenting with isolated thrombocytopenia (CCUS-IT).
    O'Neill C; Nwachukwu N; Vergara-Lluri M; Hagiya A; O'Connell CL
    Eur J Haematol; 2024 Apr; 112(4):594-600. PubMed ID: 38088145
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytopenia in autosomal dominant polycystic kidney disease (ADPKD): merely an association or a disease-related feature with prognostic implications?
    Schellekens P; Roosens W; Meyts I; Vennekens R; Bammens B; Mekahli D
    Pediatr Nephrol; 2021 Nov; 36(11):3505-3514. PubMed ID: 33502599
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytopenia after chimeric antigen receptor T cell immunotherapy in relapsed or refractory lymphoma.
    Zhou J; Zhang Y; Shan M; Zong X; Geng H; Li J; Chen G; Yu L; Xu Y; Li C; Wu D
    Front Immunol; 2022; 13():997589. PubMed ID: 36131934
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Primary Sjogren's syndrome presenting as autoimmune cytopenia.
    Meena DS; Bohra GK
    Clin Pract; 2019 Nov; 9(4):1190. PubMed ID: 31949888
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cytopenias among ART-naive patients with advanced HIV disease on enrolment to care and treatment services at a tertiary hospital in Tanzania: A cross-sectional study.
    Gunda DW; Godfrey KG; Kilonzo SB; Mpondo BC
    Malawi Med J; 2017 Mar; 29(1):43-52. PubMed ID: 28567196
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autoimmune Cytopenias Are Highly Associated with Inborn Errors of Immunity and They May Be the Initial Presentations in Cases without Severe Infections.
    Taskin RB; Topyıldız E; Edeer Karaca N; Aksu G; Yılmaz Karapınar D; Kutukculer N
    Int Arch Allergy Immunol; 2024; 185(4):392-401. PubMed ID: 38154455
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytomegalovirus infection as a cause of cytopenia after chemotherapy for hematological malignancies.
    Kanvinde S; Bhargava P; Patwardhan S
    Indian Pediatr; 2013 Feb; 50(2):197-201. PubMed ID: 22728618
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hematologic cytopenia post CAR T cell therapy: Etiology, potential mechanisms and perspective.
    Si X; Gu T; Liu L; Huang Y; Han Y; Qian P; Huang H
    Cancer Lett; 2022 Dec; 550():215920. PubMed ID: 36122628
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytopenia after CAR-T Cell Therapy-A Brief Review of a Complex Problem.
    Sharma N; Reagan PM; Liesveld JL
    Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.